[729384v1.1]
via crossref
|
Targeted cancer therapy
Charles Sawyers
2004
Nature
doi:10.1038/nature03095
pmid:15549090
|
|
[729384v1.2]
via crossref
|
Implementing Genome-Driven Oncology
David M. Hyman,
Barry S. Taylor,
José Baselga
2017
Cell
doi:10.1016/j.cell.2016.12.015
pmcid:PMC5463457
pmid:28187282
|
|
[729384v1.3]
via crossref
|
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
J. A. Engelman,
K. Zejnullahu,
T. Mitsudomi,
Y. Song,
C. Hyland,
J. O. Park,
N. Lindeman,
C.-M. Gale
(+ more)
2007
Science
doi:10.1126/science.1141478
pmid:17463250
|
web.archive.org
[PDF]
|
[729384v1.4]
via crossref
|
Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
Aaron N Hata,
Matthew J Niederst,
Hannah L Archibald,
Maria Gomez-Caraballo,
Faria M Siddiqui,
Hillary E Mulvey,
Yosef E Maruvka,
Fei Ji
(+ more)
2016
Nature Medicine
doi:10.1038/nm.4040
pmcid:PMC4900892
pmid:26828195
|
web.archive.org
[PDF]
|
[729384v1.5]
via crossref
|
Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinoma
Dana S. Neel,
Trever G. Bivona
2017
npj Precision Oncology
doi:10.1038/s41698-017-0007-0
pmcid:PMC5687582
pmid:29152593
|
web.archive.org
[PDF]
|
[729384v1.6]
via crossref
|
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance
Sydney M. Shaffer,
Margaret C. Dunagin,
Stefan R. Torborg,
Eduardo A. Torre,
Benjamin Emert,
Clemens Krepler,
Marilda Beqiri,
Katrin Sproesser
(+ more)
2017
Nature
doi:10.1038/nature22794
pmcid:PMC5542814
pmid:28607484
|
web.archive.org
[PDF]
|
[729384v1.7]
via crossref
|
Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab
Toni M. Brand,
Mari Iida,
Deric L. Wheeler
2011
Cancer Biology & Therapy
doi:10.4161/cbt.11.9.15050
pmcid:PMC3100630
pmid:21293176
|
web.archive.org
[PDF]
|
[729384v1.8]
via crossref
|
CETUXIMAB: From Bench to Bedside
B. Vincenzi,
A. Zoccoli,
F. Pantano,
O. Venditti,
S. Galluzzo
2010
Current Cancer Drug Targets
doi:10.2174/156800910790980241
pmid:20088790
|
|
[b8]
via grobid
|
Grandis JR, Tweardy DJ. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res. 1993;53:3579-84.
|
|
[729384v1.10]
via crossref
|
Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival
Jennifer Rubin Grandis,
Mona F. Melhem,
William E. Gooding,
Roger Day,
Valerie A. Holst,
Marilyn M. Wagener,
Stephanie D. Drenning,
David J. Tweardy
1998
Journal of the National Cancer Institute
doi:10.1093/jnci/90.11.824
pmid:9625170
|
web.archive.org
[PDF]
|
[729384v1.11]
via crossref
|
Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response
Carolien Boeckx,
Christine Weyn,
Isabelle Vanden Bempt,
Vanessa Deschoolmeester,
An Wouters,
Pol Specenier,
Carl Van Laer,
Danielle Van den Weyngaert
(+ more)
2014
BMC Research Notes
doi:10.1186/1756-0500-7-337
pmcid:PMC4067106
pmid:24899223
|
web.archive.org
[PDF]
|
[729384v1.12]
via crossref
|
CoGAPS matrix factorization algorithm identifies transcriptional changes in AP-2alpha target genes in feedback from therapeutic inhibition of the EGFR network
Elana J. Fertig,
Hiroyuki Ozawa,
Manjusha Thakar,
Jason D. Howard,
Luciane T. Kagohara,
Gabriel Krigsfeld,
Ruchira S. Ranaweera,
Robert M. Hughes
(+ more)
2016
OncoTarget
doi:10.18632/oncotarget.12075
pmcid:PMC5342018
pmid:27650546
|
web.archive.org
[PDF]
|
[729384v1.13]
via crossref
|
Cetuximab promotes epithelial to mesenchymal transition and cancer associated fibroblasts in patients with head and neck cancer
Sandra Schmitz,
Gabriela Bindea,
Roxana Irina Albu,
Bernhard Mlecnik,
Jean-Pascal Machiels
2015
OncoTarget
doi:10.18632/oncotarget.5924
pmcid:PMC4741452
pmid:26437222
|
web.archive.org
[PDF]
|
[729384v1.14]
via crossref
|
TRANSFAC(R): transcriptional regulation, from patterns to profiles
V. Matys
2003
Nucleic Acids Research
doi:10.1093/nar/gkg108
pmcid:PMC165555
pmid:12520026
|
web.archive.org
[PDF]
|
[729384v1.15]
via crossref
|
TRANSFAC(R) and its module TRANSCompel(R): transcriptional gene regulation in eukaryotes
V. Matys
2006
Nucleic Acids Research
doi:10.1093/nar/gkj143
pmcid:PMC1347505
pmid:16381825
|
web.archive.org
[PDF]
|
[729384v1.16]
via crossref
|
DecreasedSMAD4expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma
Haixia Cheng,
Elana J Fertig,
Hiroyuki Ozawa,
Hiromitsu Hatakeyama,
Jason D Howard,
Jimena Perez,
Michael Considine,
Manjusha Thakar
(+ more)
2015
Cancer Biology & Therapy
doi:10.1080/15384047.2015.1056418
pmcid:PMC4623002
pmid:26046389
|
web.archive.org
[PDF]
|
[729384v1.17]
via crossref
|
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A Singh,
J Settleman
2010
Oncogene
doi:10.1038/onc.2010.215
pmcid:PMC3176718
pmid:20531305
|
web.archive.org
[PDF]
|
[729384v1.18]
via crossref
|
Epithelial-to-Mesenchymal Transition and Integrin-Linked Kinase Mediate Sensitivity to Epidermal Growth Factor Receptor Inhibition in Human Hepatoma Cells
B. C. Fuchs,
T. Fujii,
J. D. Dorfman,
J. M. Goodwin,
A. X. Zhu,
M. Lanuti,
K. K. Tanabe
2008
Cancer Research
doi:10.1158/0008-5472.can-07-2460
pmid:18381447
|
web.archive.org
[PDF]
|
[729384v1.19]
via crossref
|
Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs
Marc Hafner,
Mario Niepel,
Mirra Chung,
Peter K Sorger
2016
Nature Methods
doi:10.1038/nmeth.3853
pmcid:PMC4887336
pmid:27135972
|
web.archive.org
[PDF]
|
[729384v1.20]
via crossref
|
Salmon provides fast and bias-aware quantification of transcript expression
Rob Patro,
Geet Duggal,
Michael I Love,
Rafael A Irizarry,
Carl Kingsford
2017
Nature Methods
doi:10.1038/nmeth.4197
pmcid:PMC5600148
pmid:28263959
|
web.archive.org
[PDF]
|
[729384v1.21]
via crossref
|
Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences
Charlotte Soneson,
Michael I. Love,
Mark D. Robinson
2015
F1000Research
doi:10.12688/f1000research.7563.1
pmcid:PMC4712774
pmid:26925227
|
web.archive.org
[PDF]
|
[729384v1.22]
via crossref
|
Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position
Jason D Buenrostro,
Paul G Giresi,
Lisa C Zaba,
Howard Y Chang,
William J Greenleaf
2013
Nature Methods
doi:10.1038/nmeth.2688
pmcid:PMC3959825
pmid:24097267
|
web.archive.org
[PDF]
|
[b22]
via grobid
|
Andrews S. FastQC: a quality control tool for high throughput sequence data [Internet]. 2010. Available from: http://www.bioinformatics.babraham.ac.uk/projects/fastqc
|
|
[729384v1.24]
via crossref
|
Fast gapped-read alignment with Bowtie 2
Ben Langmead,
Steven L Salzberg
2012
Nature Methods
doi:10.1038/nmeth.1923
pmcid:PMC3322381
pmid:22388286
|
web.archive.org
[PDF]
|
[729384v1.25]
via crossref-grobid
|
Picard Tools Version 2
A Wysoker
,
K Tibbetts
,
T Fennell
url:http://broadinstitute.github.io/picard/
|
|
[729384v1.26]
via crossref
|
The Sequence Alignment/Map format and SAMtools
H. Li,
B. Handsaker,
A. Wysoker,
T. Fennell,
J. Ruan,
N. Homer,
G. Marth,
G. Abecasis
(+ more)
2009
Bioinformatics
doi:10.1093/bioinformatics/btp352
pmcid:PMC2723002
pmid:19505943
|
web.archive.org
[PDF]
|
[729384v1.27]
via crossref
|
Model-based Analysis of ChIP-Seq (MACS)
Yong Zhang,
Tao Liu,
Clifford A Meyer,
Jérôme Eeckhoute,
David S Johnson,
Bradley E Bernstein,
Chad Nussbaum,
Richard M Myers
(+ more)
2008
Genome Biology
doi:10.1186/gb-2008-9-9-r137
pmcid:PMC2592715
pmid:18798982
|
web.archive.org
[PDF]
|
[729384v1.28]
via crossref-grobid
|
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
C S Ross-Innes
,
R Stark
,
A E Teschendorff
,
K A Holmes
,
H R Ali
,
M J Dunning
2012
Nature
doi:10.1038/nature10730
url:http://www.nature.com/doifinder/10.1038/nature10730
|
|
[729384v1.29]
via crossref
|
NIH Image to ImageJ: 25 years of image analysis
Caroline A Schneider,
Wayne S Rasband,
Kevin W Eliceiri
2012
Nature Methods
doi:10.1038/nmeth.2089
pmcid:PMC5554542
pmid:22930834
|
web.archive.org
[PDF]
|
[729384v1.30]
via crossref
|
Efficacy of gemcitabine and cetuximab combination treatment in head and neck squamous cell carcinoma
SHINICHIRO MASEKI,
KEI IJICHI,
HAYAO NAKANISHI,
YASUHISA HASEGAWA,
TETSUYA OGAWA,
SHINGO MURAKAMI
2013
Molecular and clinical oncology
doi:10.3892/mco.2013.159
pmcid:PMC3916031
pmid:24649271
|
archive.org
[PDF]
|